Colorectal Surgery
MD, Director, Colorectal Surgery Department, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; President, Shanxi Hospital of Cancer Hospital Chinese Academy of Medical Sciences, China
Dr. Xishan Wang is a leading expert in colorectal surgery, holding key roles in medical institutions and professional associations. As the Director of the Colorectal Surgery Department at the National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences/Peking Union Medical College, he also serves as President at the Shanxi Hospital of the Cancer Hospital Chinese Academy of Medical Sciences.
In his academic capacity, Dr. Wang chairs the Colorectal Cancer Committee of the Chinese Medical Doctor Association and the Chinese Anti-Cancer Association. He is also President of both the International Alliance of Natural Orifice Specimen Extraction Surgery and the China Alliance of Natural Orifice Specimen Extraction Surgery. Dr. Wang edits the Chinese Journal of Colorectal Diseases (Electronic Edition).
Dr. Wang's research contributions include over 200 published papers and involvement in various national projects, including the National Major Project of Precision Medicine focusing on colorectal cancer diagnosis and treatment.
Known for expertise in minimally invasive colorectal surgery, Dr. Wang has pioneered techniques such as natural orifice specimen extraction surgery (NOSES) and refined approaches to colorectal cancer treatment. His work has significantly impacted the field, improving patient outcomes and advancing surgical practices.
Selected publications from PubMed
Developing Personalized Postoperative Follow-Up Strategies for Patients With Locally Advanced Gastric Cancer Receiving Neoadjuvant Therapy Based on Dynamic Programming: A Multicenter Retrospective Cohort Study in China.
Li T, Yang Z, Liu C, Lian L, Lin J, Zhang P, Xiao H, Wang X, Tang Z, Li W, Tao K, Sheng W, Cao Y, Wang L, Sun J, Zhang Z, Shi Z, Yin J, Wang Z, Cao S, Yuan S, Liu X, Shang L, Zhao Y, Tao K
Int J Cancer. 2026 Sep 1 doi: 10.1002/ijc.70731.
Threshold association analysis between residual tumour size and distant metastasis risk after neoadjuvant therapy for rectal cancer: A multicentre retrospective study.
Zeng H, Xue X, Chen D, Wang X, Lan K, Yuan Z, Gan W, Liao B, Wu B, Xu D, Zeng B, Chi P, Lin S, Huang Y
Colorectal Dis. 2026 Sep;28(9):e70563 doi: 10.1111/codi.70563.
Delivery Strategies for Oncolytic Viruses in Gastrointestinal Cancers: Progress, Mechanisms and Clinical Translations.
Xue C, Liu Y, Yin C, Guo R, Ju M, Zhang Y, Xiao F, Wang X, Iko H, Guo ZS, Zhu Z
Rev Med Virol. 2026 Sep;36(5):e70186 doi: 10.1002/rmv.70186.
Five-Year Outcomes of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy for Locally Advanced Rectal Cancer: Updated Results of the STELLAR Trial.
Tang Y, Zhou HT, Xu TZ, Li N, Jiang LM, Jiang J, Lu NN, Li S, Chen SL, Ma HY, Cai Y, Li YH, Zhu Y, He MY, Wang X, Liu K, Zhang HY, Wang J, Zhao T, Li GF, Yang JL, Zhang K, Wang WL, Xiao WW, Chi Y, Yang L, Zhou AP, Zou SM, Fang H, Wang SL, Zhang HZ, Wang XS, Wei LC, Liu SX, Gao YH, Li YX, Hu C, Jin J
J Clin Oncol. 2026 Sep;44(25):2371-2378 doi: 10.1200/JCO-25-02387.
Single-Cell Profiling Reveals Distinct Immune Hallmarks in Untreated Primary Colorectal and Liver Metastasis Cancers.
Zhao Z, Chen H, Guan X, Jiang Z, Liu Z, Yang M, Liu H, Chen T, Zou S, Gao Y, Wang X
Chronic Dis Transl Med. 2026 Sep;12(3):197-208 doi: 10.1002/cdt3.70051.
Help your network discover Dr. Xishan Wang's clinical expertise.
.webp)